RE:RE:RE:RE:RE:“Second mouse gets the cheese “CG oncology’s Oncolytic virus is very significant I think moving forward. Watched the Endpoints Webinar on Oncolytics viruses recently and the original work done on V-TEC by Howard Kaufman, he was pretty certain that CG Oncology would have next virus approval by FDA<br /> <br /> Howard Kaufman was involved early with OV and 1st FDA approval. TVEC. <div> Currently CEO of ANKYRA Therapeutics. <br /> <br /> </div>